Literature DB >> 3651438

Reaction of Lactobacillus histidine decarboxylase with L-histidine methyl ester.

T A Alston1, R H Abeles.   

Abstract

L-Histidine methyl ester inactivates histidine decarboxylase in a time-dependent manner. The possibility was considered that an irreversible reaction between enzyme and inhibitor occurs [Recsei, P. A., & Snell, E. E. (1970) Biochemistry 9, 1492-1497]. We have confirmed time-dependent inactivation by histidine methyl ester and have investigated the structure of the enzyme-inhibitor complex. Upon exposure to either 8 M guanidinium chloride or 6% trichloroacetic acid, unchanged histidine methyl ester is recovered. Formation of the complex involves Schiff base formation, most likely with the active site pyruvyl residue [Huynh, Q. K., & Snell, E. E. (1986) J. Biol. Chem. 261, 4389-4394], but does not involve additional irreversible covalent interaction between inhibitor and enzyme. Complex formation is a two-step process involving rapidly reversible formation of a loose complex and essentially irreversible formation of a tight complex. For the formation of the tight complex, Ki = 80 nM and koff = 2.5 X 10(-4) min-1. Time-dependent inhibition was also observed with L-histidine ethyl ester, L-histidinamide, and DL-3-amino-4-(4-imidazolyl)-2-butanone. No inactivation was observed with glycine methyl ester or histamine. We propose that in the catalytic reaction the carboxyl group of the substrate is in a hydrophobic region. The unfavorable interaction between the carboxylate group and the hydrophobic region facilitates decarboxylation [Crosby, J., Stone, R., & Liehard, G. E. (1970) J. Am. Chem. Soc. 92, 2891-2900]. With histidine methyl ester this unfavorable interaction is no longer present; hence, there is tight binding.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3651438     DOI: 10.1021/bi00387a051

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  2 in total

1.  Immune Responses in Malaria and Vaccine Strategies.

Authors:  Janez Ferluga; Iesha Singh; Sashmita Rout; Ahmed Al-Qahtani; Hadida Yasmin; Uday Kishore
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity.

Authors:  Agnes Mwakingwe-Omari; Sara A Healy; Jacquelyn Lane; David M Cook; Sahand Kalhori; Charles Wyatt; Aarti Kolluri; Omely Marte-Salcedo; Alemush Imeru; Martha Nason; Lei K Ding; Hope Decederfelt; Junhui Duan; Jillian Neal; Jacob Raiten; Grace Lee; Jen C C Hume; Jihyun E Jeon; Ijeoma Ikpeama; Natasha Kc; Sumana Chakravarty; Tooba Murshedkar; L W Preston Church; Anita Manoj; Anusha Gunasekera; Charles Anderson; Sean C Murphy; Sandra March; Sangeeta N Bhatia; Eric R James; Peter F Billingsley; B Kim Lee Sim; Thomas L Richie; Irfan Zaidi; Stephen L Hoffman; Patrick E Duffy
Journal:  Nature       Date:  2021-06-30       Impact factor: 49.962

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.